PharmAla Biotech Logo 800 x 422.png
USFDA Approves LaNeo MDMA for Clinical Trial Use in the United States
09 juin 2023 15h48 HE | PharmAla Biotech
Approved Study to Examine Tolerability of MDMA in Schizophrenia at UCLA VANCOUVER, British Columbia, June 09, 2023 (GLOBE NEWSWIRE) -- PharmAla Biotech Holdings Inc. (“PharmAla”)(CSE:...
PrimaryLogo_Mango-05.png
Mangoceuticals Signs Deal with BarStool Sports to Market Mango on Popular “Only Stans” Podcast
08 juin 2023 09h00 HE | Mangoceuticals, Inc.
Dallas, Texas, June 08, 2023 (GLOBE NEWSWIRE) -- Mangoceuticals, Inc. (NASDAQ:MGRX) (“MangoRx” or the “Company”), a company focused on developing, marketing and selling a variety of men’s health and...
Kronos-Logo-400px.jpg
KRONOS ADVANCED TECHNOLOGIES FDA-CLEARED AIR PURIFIERS PROVIDE RELIEF FROM CANADIAN WILDFIRE SMOKE
08 juin 2023 06h18 HE | Kronos Advanced Technologies Inc.
Parkersburg, WV, June 08, 2023 (GLOBE NEWSWIRE) -- Parkersburg, WV June 8, 2023 (GLOBE NEWSWIRE) -- KRONOS ADVANCED TECHNOLOGIES, INC. (OTC MARKETS: KNOS) ("KNOS" or the "Company"),...
Nouveau Logo communiqué de presse.JPG
Theratechnologies Receives FDA Agreement to Amended Trial Protocol for its Lead PDC Candidate Sudocetaxel Zendusortide
02 juin 2023 12h15 HE | Theratechnologies
Phase 1 trial to resume with weekly dosing, a focus on patients with ovarian cancer and refined patient selectionJune 13 call for investors and analysts with trial investigators to provide insights on...
Nouveau Logo communiqué de presse.JPG
La FDA approuve la modification du protocole de l’essai de Theratechnologies portant sur son principal CPM expérimental, le sudocétaxel zendusortide
02 juin 2023 12h15 HE | Theratechnologies
L’essai de phase I est prévu reprendre avec un schéma posologique hebdomadaire, tout en mettant l’accent sur les patientes atteintes d’un cancer de l’ovaire, et avec une sélection affinée des...
Quicktome FC by Omniscient Neurotechnology
Omniscient Announces FDA-Clearance of New MRI-based Functional Brain Analysis Technology
02 juin 2023 10h00 HE | Omniscient Neurotechnology
FDA-cleared AI brain-mapping software, Quicktome FC (Functional Connectome), maps functional connectivity of a patient’s unique networks - involved in crucial functions such as movement, language, and...
ihl_logo.png
World Renowned International Psychedelics Experts Join Clarion Clinics Advisory Board
30 mai 2023 08h00 HE | Incannex Healthcare
Highlights: Three world-leading clinical psychedelics experts join Clarion Clinics Advisory Board.Dr. Bill Richards is among the world’s best known psychedelic researchers and practitioners. He has...
Kane Logo Cropped TransBG.png
Kane Biotech Announces First Quarter 2023 Financial Results
25 mai 2023 16h05 HE | Kane Biotech Inc.
WINNIPEG, Manitoba, May 25, 2023 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (the “Company” or “Kane Biotech”), a biotechnology company engaged in the research, development and...
Excipient Gel Vial
FDA Approves Groundbreaking New Product Utilizing Berkshire Sterile Excipient Gel to Treat 'Butterfly Children'
25 mai 2023 11h10 HE | Berkshire Sterile Manufacturing
Lee, MA, May 25, 2023 (GLOBE NEWSWIRE) -- On May 19, 2023, Krystal Biotech, a client of Berkshire Sterile Manufacturing (BSM), received FDA approval for VYJUVEK™, the first-ever topical gene therapy...
coactiv wound gel
Kane Biotech Announces FDA 510(k) Clearance for its coactiv+™ Antimicrobial Wound Gel
25 mai 2023 10h38 HE | Kane Biotech Inc.
WINNIPEG, Manitoba, May 25, 2023 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE OTCQB:KNBIF) (the “Company” or “Kane Biotech”) announces that on May 24, 2023 it received 510(k) clearance of its...